ATC code L02

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ATC codes
L Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L02 Endocrine therapy
L03 Immunostimulants
L04 Immunosuppressants

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL02...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02A Hormones and related agents[edit]

L02AA Estrogens[edit]

L02AA01 Diethylstilbestrol
L02AA02 Polyestradiol phosphate
L02AA03 Ethinylestradiol
L02AA04 Fosfestrol

L02AB Progestogens[edit]

L02AB01 Megestrol
L02AB02 Medroxyprogesterone
L02AB03 Gestonorone

L02AE Gonadotropin-releasing hormone analogues[edit]

L02AE01 Buserelin
L02AE02 Leuprorelin
L02AE03 Goserelin
L02AE04 Triptorelin
L02AE05 Histrelin

L02AX Other hormones[edit]

L02B Hormone antagonists and related agents[edit]

L02BA Anti-estrogens[edit]

L02BA01 Tamoxifen
L02BA02 Toremifene
L02BA03 Fulvestrant

L02BB Anti-androgens[edit]

L02BB01 Flutamide
L02BB02 Nilutamide
L02BB03 Bicalutamide

L02BG Aromatase inhibitors[edit]

L02BG01 Aminogluthetimide
L02BG02 Formestane
L02BG03 Anastrozole
L02BG04 Letrozole
L02BG05 Vorozole
L02BG06 Exemestane

L02BX Other hormone antagonists and related agents[edit]

L02BX01 Abarelix
L02BX02 Degarelix
L02BX03 Abiraterone

References[edit]

  1. ^ "ATC/DDD Index 2014: code L02". WHO Collaborating Centre for Drug Statistics Methodology. 
  2. ^ "ATCvet Index 2014: code QL02". WHO Collaborating Centre for Drug Statistics Methodology.